Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trial

Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trial

AimTo determine the safety and efficacy of a 0.5% povidone-iodine nasal spray (Nasodine) as a treatment for the common cold (ACTRN12619000764134).MethodsA multi-center, randomized, controlled, double-blind Phase III study was conducted to assess the impact of Nasodine on the common cold. Two hundred...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas M. Polasek, Peter L. Friedland
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Medicine
Subjects:
povidone-iodine
upper respiratory tract infections (URTIs)
Nasodine
nasal spray
common cold
clinical trial
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1565069/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items